Stay updated on Pembrolizumab Combo With Local Ablation in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T01:02:38.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the previous Revision: v3.4.1 notice, along with removing the funding status operating notice.
    Difference
    0.4%
    Check dated 2026-02-11T14:22:51.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the page version updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:31:01.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A glossary is now displayed, and the QC update label has been capitalized from 'Last Update Submitted that met QC Criteria' to 'Last Update Submitted that Met QC Criteria'. The No FEAR Act Data label appears with updated capitalization, replacing the previous 'No FEAR Act data', and the revision reference updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:24:03.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:55:20.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section added for Lower Saxony, listing Hanover, Germany as a study site. The HHS Vulnerability Disclosure link in the footer was removed.
    Difference
    0.2%
    Check dated 2025-12-23T13:38:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo With Local Ablation in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.